Clinical Considerations for Pain Management of Monkeypox

Published: 09/23/2022

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Home Health,
  • Hospitals,
  • Ambulatory Care,
  • Rural Health Clinics

According to the U.S. Centers for Disease Control and Prevention (CDC), all patients with monkeypox benefit from supportive care and pain control that is started early in the illness. For most patients with healthy immune systems, supportive care and pain control may be enough. However, there are some instances where TPOXX could be beneficial, and CDC has updated guidance to reflect this.

The CDC has updated its Guidance for Tecovirimat (TPOXX) Use Under Expanded Access Investigational New Dr

Sign Up for Free Trial